Výsledky vyhledávání - "Helena, Pomares"

Akademický článek

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

IntroductionChronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or SF3B1 mutation (MDS-RS/SF3B1) differ in many clinical features, but share others, such as anemia. RS and SF3B1 mutation can also be

Externí odkaz: https://doaj.org/article/4dbd47cd35b34b73b6084f1ab4ddcba5

Zobrazit plný text záznamu

Akademický článek

Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes

Publikováno v: Therapeutic Advances in Hematology, Vol 15 (2024)

Background: Erythropoiesis stimulating agents (ESAs) are the first-line therapy in patients with lower-risk myelodysplastic syndromes (LR-MDS). Some predictive factors for ESAs response have been identified. Type and number of somatic mutations have

Externí odkaz: https://doaj.org/article/aae5bf162b0d4831a1ded6c9dd145238

Zobrazit plný text záznamu

Akademický článek

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Publikováno v: HemaSphere, Vol 7, Iss 10, p e961 (2023)

Myelodysplastic neoplasms (MDS) are a heterogeneous group of hematological stem cell disorders characterized by dysplasia, cytopenias, and increased risk of acute leukemia. As prognosis differs widely between patients, and treatment options vary from

Externí odkaz: https://doaj.org/article/8be230579faa4438bea41bbeeacb89de

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Increasing Gram-Negative Catheter-Related Bloodstream Infection in Cancer Patients

Autor: Julia Laporte-Amargos, Enric Sastre, Alba Bergas, Helena Pomares, Annalisa Paviglianiti, Marisol Rodriguez-Arias, Natalia Pallares, Ana Maria Badia-Tejero, Paula Pons-Oltra, Jordi Carratalà, Carlota Gudiol

Publikováno v: Pathogens, Vol 12, Iss 2, p 228 (2023)

Background: We aimed to assess the incidence, etiology and outcomes of catheter-related bloodstream infection (CRBSI) in onco-hematological patients, to assess the differences between patients with hematological malignancies (HMs) and solid tumors (S

Externí odkaz: https://doaj.org/article/e86dbb14d5e646e2844a2290b6ed8718

Zobrazit plný text záznamu

Akademický článek

The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting

Publikováno v: Cancer Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)

Abstract Background Clinical outcomes of novel coronavirus 2019 disease (COVID‐19) in onco‐hematological patients are unknown. When compared to non‐immunocompromised patients, onco‐hematological patients seem to have higher mortality rates. A

Externí odkaz: https://doaj.org/article/b199fbf0402549ec9e8d7cc78f8eda23

Zobrazit plný text záznamu

Akademický článek

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

Autor: Laura Palomo, Roberto Malinverni, Marta Cabezón, Blanca Xicoy, Montserrat Arnan, Rosa Coll, Helena Pomares, Olga García, Francisco Fuster-Tormo, Javier Grau, Evarist Feliu, Francesc Solé, Marcus Buschbeck, Lurdes Zamora

Publikováno v: Epigenetics, Vol 13, Iss 1, Pp 8-18 (2018)

Chromosomal abnormalities are detected in 20–30% of patients with chronic myelomonocytic leukemia (CMML) and correlate with prognosis. On the mutation level, disruptive alterations are particularly frequent in chromatin regulatory genes. However, l

Externí odkaz: https://doaj.org/article/04c967ed20c64ccc8fee7f564a6fefa8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání